Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TENAPANOR for Hyperphosphataemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 598 adverse event reports in the FDA FAERS database where TENAPANOR was used for Hyperphosphataemia.

Most Reported Side Effects for TENAPANOR

Side Effect Reports % Deaths Hosp.
Diarrhoea 793 41.0% 29 136
Death 222 11.5% 220 40
Hospitalisation 138 7.1% 25 138
Inappropriate schedule of product administration 115 5.9% 1 14
Off label use 94 4.9% 4 34
Product use issue 72 3.7% 2 29
Nausea 59 3.1% 1 14
Abdominal distension 52 2.7% 1 10
Therapy interrupted 52 2.7% 1 24
Abdominal pain 50 2.6% 3 13
Product use in unapproved indication 47 2.4% 4 15
Vomiting 47 2.4% 1 17
Dehydration 40 2.1% 1 21
Abdominal pain upper 38 2.0% 0 9
Dizziness 33 1.7% 0 6

Other Indications for TENAPANOR

Chronic kidney disease (525) Product used for unknown indication (451) Irritable bowel syndrome (332) Constipation (59) End stage renal disease (21) Blood phosphorus increased (16) Multiple drug therapy (8) Hypophosphataemia (6) Nephropathy (6) Blood phosphorus abnormal (5)

Other Drugs Used for Hyperphosphataemia

TETRAFERRIC TRICITRATE DECAHYDRATE (682) SEVELAMER (533) LANTHANUM (528) FERRIC OXYHYDROXIDE (492) FERRIC ANHYDROUS (275) SUCROFERRIC OXYHYDROXIDE (124) CALCIUM (76) 405 (24) RENVELA (22) FOSRENOL (16)

Related Pages

TENAPANOR Full Profile All Hyperphosphataemia Drugs TENAPANOR Demographics TENAPANOR Timeline